Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 31, 2011

Definiens to Develop Image Analysis Application for ACD

  • Definiens will develop an image analysis application for Advanced Cell Diagnostics (ACD) that will automatically process and analyze images from assays carried out through ACD’s RNAscope biomarker analysis and diagnostics platform.

    The partnership will build on Definiens software, based on the Definiens XD framework, as well as on ACD's RNAscope, a multiplex fluorescent and chromogenic in situ hybridization platform. Definiens XD is designed to offer users accurate, robust, and scalable image analysis solutions for a range of histology analysis applications, says the firm.RNAscope is designed to detect and quantify RNA biomarkers in situ at single molecule sensitivity in individual cells in all major biological specimen types including cell lines, PBMC, and FFPE tissue sections.

    "This advanced image analysis solution will bring objective and accurate quantification to RNAscope and enable a new generation of diagnostic applications such as circulating tumor cell detection and molecular analysis,” says Yuling Luo, Ph.D., ACD's founder, president, and CEO.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »